| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash and cash equivalents | $467.7M+2.6% | $455.7M+3.0% | $442.6M+10.0% | $402.5M |
| Marketable securities | $396.4M+8.7% | $364.6M | $0 | — |
| Accounts receivable, net | $74.0M+17.4% | $63.0M+21.0% | $52.1M+55.1% | $33.6M |
| Prepaid expenses and other current assets | $50.1M+22.0% | $41.0M+38.6% | $29.6M-20.5% | $37.2M |
| Tax receivable | $1.8M | $0 | — | — |
| Inventory, net | $6.7M+23.8% | $5.4M+21.0% | $4.5M+550.4% | $692K |
| Total current assets | $996.7M+7.2% | $929.9M+75.8% | $528.8M+11.6% | $474.0M |
| Property and equipment, net | $11.5M+13.6% | $10.1M+9.5% | $9.2M+17.6% | $7.8M |
| Operating lease right of use assets, net | $38.8M+3.0% | $37.6M+12.3% | $33.5M+8.3% | $30.9M |
| Deferred tax assets, net | $0-100.0% | $14.8M+34.8% | $11.0M+114.3% | $5.1M |
| Other non-current assets | $20.3M+18.5% | $17.1M+18.3% | $14.5M+62.9% | $8.9M |
| Total assets | $1.07B+5.7% | $1.01B+69.1% | $597.0M+13.3% | $526.8M |
| Accounts payable | $24.4M-2.9% | $25.1M+41.0% | $17.8M+23.2% | $14.4M |
| Accrued expenses and other current liabilities | $219.7M+18.4% | $185.5M+54.8% | $119.8M+56.1% | $76.7M |
| Deferred revenue, current | $583K | $0 | — | $7.8M |
| Operating lease liabilities, current | $2.0M+29.7% | $1.5M+11.5% | $1.4M-26.2% | $1.9M |
| Total current liabilities | $246.7M+16.3% | $212.2M+52.6% | $139.0M+37.9% | $100.8M |
| Deferred revenue, non-current | $4.9M-10.6% | $5.4M-1.5% | $5.5M+5.2% | $5.2M |
| Operating lease liabilities, non-current | $41.6M+3.5% | $40.2M+12.8% | $35.6M+12.1% | $31.8M |
| Interest-bearing loans and borrowings | $393.1M+0.5% | $391.0M+714.4% | $48.0M+0.4% | $47.8M |
| Total liabilities | $686.2M+5.8% | $648.8M+184.4% | $228.2M+21.5% | $187.9M |
| Ordinary shares (voting and non-voting), £0.002 par value, most recent authority to allot up to a maximum nominal value of £149,633 and £97,454 shares as of December 31, 2025 and 2024, respectively, and 50,689,271 and 50,064,860 shares issued and outstanding as of December 31, 2025 and 2024, respectively. | $136K+0.7% | $135K+0.7% | $134K+3.9% | $129K |
| Deferred shares, £0.0001 par value, 5,793,501 shares authorized, issued and outstanding as of December 31, 2025 and 2024. | $1K+0.0% | $1K+0.0% | $1K+0.0% | $1K |
| Additional paid-in capital | $1.24B+4.2% | $1.19B+3.5% | $1.15B+6.2% | $1.08B |
| Accumulated deficit | -$831.3M-4.5% | -$795.8M-6.9% | -$744.7M-8.0% | -$689.4M |
| Accumulated other comprehensive loss | -$28.1M+16.8% | -$33.8M+6.9% | -$36.3M+33.7% | -$54.7M |
| Total shareholders’ equity | $381.0M+5.6% | $360.7M-2.2% | $368.8M+8.8% | $338.9M |
| Total liabilities and shareholders’ equity | $1.07B+5.7% | $1.01B+69.1% | $597.0M+13.3% | $526.8M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.